Aurora Espinosa

ORCID: 0009-0004-5710-3278
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood transfusion and management
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Blood donation and transfusion practices
  • Blood groups and transfusion
  • Prenatal Screening and Diagnostics
  • Ocular Surface and Contact Lens
  • Retinal Diseases and Treatments
  • Parvovirus B19 Infection Studies
  • Glaucoma and retinal disorders
  • Congenital Anomalies and Fetal Surgery
  • Hemoglobinopathies and Related Disorders
  • Erythrocyte Function and Pathophysiology
  • Hemostasis and retained surgical items
  • LGBTQ Health, Identity, and Policy
  • Hemodynamic Monitoring and Therapy
  • Trauma and Emergency Care Studies
  • Lymphoma Diagnosis and Treatment
  • Periodontal Regeneration and Treatments
  • Congenital heart defects research
  • Race, Genetics, and Society
  • Congenital limb and hand anomalies
  • Corneal Surgery and Treatments
  • Syphilis Diagnosis and Treatment
  • Sepsis Diagnosis and Treatment
  • Pressure Ulcer Prevention and Management

Norwegian Directorate of Health
2024

Oslo University Hospital
2021-2024

St Olav's University Hospital
2002-2019

Nasjonalt Kunnskapssenter for Helsetjenesten
2010-2013

Centro Científico Tecnológico - Bahía Blanca
2008-2009

Baxter (Belgium)
2008

UCLouvain
2008

Camilo José Cela University
2008

Azienda USL di Pescara
2008

Cerus (United States)
2008

BACKGROUND: Inactivation of pathogens and white blood cells in platelet (PLT) components with amotosalen UVA light (INTERCEPT, Cerus Europe BV) has entered clinical practice European centers. A prospective cohort study was implemented to characterize the safety profile this new PLT component a broad patient population. STUDY DESIGN AND METHODS: Apheresis or buffy‐coat were leukoreduced, suspended approximately 35 percent plasma 65 additive solution, treated INTERCEPT process. Blood centers...

10.1111/j.1537-2995.2008.01643.x article EN Transfusion 2008-03-13

Bleeding complications in cardiac surgery may lead to increased morbidity and mortality. Traditional blood coagulation tests are not always suitable detect rapid changes the patient's status. Point-of-care instruments such as TEG (thromboelastograph) RoTEM (thromboelastometer) have been shown be useful a guide for clinician choice of products they reduction need transfusion, contributing better patient management. The purpose this study was evaluate ability TEG, Sonoclot hemostasis elective...

10.1186/1471-2253-14-80 article EN cc-by BMC Anesthesiology 2014-09-22

Respiratory tract diseases are among the most common infections of childhood and adolescence. Probiotics in recent years have been presented as a promise prophylactic curative alternative for various digestive, mental respiratory pathologies. This is attributed to great influence that intestinal microbiota exerts on immune system. Multiple studies indicate an impact due external or internal factors generates alteration Among uses currently exist, they used prevention treatment children,...

10.18203/2320-6012.ijrms20250290 article EN International Journal of Research in Medical Sciences 2025-01-30

Intensive care unit (ICU) patients usually have abnormal biochemical and hematological laboratory test results as a consequence of organ dysfunction underlying disease. Thromboelastography (TEG®) is point-of-care analysis that gives an overview several aspects the coagulation process. In order to be able perform clinical interpretation TEG® expected values from non-bleeding ICU should known. The aim this study report normal variability observed in non-bleeding, non-transfused patients. Adult...

10.1186/s12871-015-0011-2 article EN cc-by BMC Anesthesiology 2015-03-06

To reduce the risk of RhD alloimmunization during last trimester pregnancy, a targeted routine antenatal anti-D prophylaxis (RAADP) programme was implemented in Norway 2016. Here, we present and discuss our experience with nationwide implementation programme, report sample uptake preliminary data de novo pregnancy.The RAADP advised by academic community evaluated health authorities. A National Working Group has conducted transfusion services contributed to organise administration...

10.1111/tme.12772 article EN Transfusion Medicine 2021-04-05

We report a case of aberrant expression the T cell antigen CD8 in patient with B chronic lymphocytic leukaemia (B-CLL). A 62-year-old Caucasian female several enlarged lymph nodes and suspected to have B-CLL was referred our laboratory for routine immunophenotyping. Peripheral blood count showed moderate leucocytosis without other abnormalities. The dual-colour flow cytometric analysis typical phenotype (CD45+, CD19+, κ +, m, CD20+, CD23+, IgM+, HLA-DR+, CD5/CD19+, CD3 m ). In addition,...

10.1080/1042819021000054689 article EN Leukemia & lymphoma/Leukemia and lymphoma 2002-11-20

The aim of this study was to analyse the reports received in Norwegian Haemovigilance System from 2004 2020 on acute and delayed haemolytic transfusion reactions caused by non-ABO red cell antibodies.

10.1111/vox.13605 article EN Vox Sanguinis 2024-02-19

Abstract Introduction This study aimed to identify the blood transfusion rates for several surgical procedures in a single district general hospital and assess value of preoperative type antibody screen across all relevant procedures. We hypothesized that there was an overuse our population. Methods A database containing transfusions patients who underwent elective‐ or emergency surgery from January 2015 September 2020 matched type‐and‐screen performed same period. Registered where incidence...

10.1111/aas.14493 article EN cc-by Acta Anaesthesiologica Scandinavica 2024-07-09
Coming Soon ...